Call for Abstract

3rd Middle East Pharmacy and Pharmaceutical Conference, will be organized around the theme “”

Pharma Conference 2020 is comprised of 16 tracks and 109 sessions designed to offer comprehensive sessions that address current issues in Pharma Conference 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Herbal Novel Drug Delivery
  • Track 1-2Nanotechnology in Drug Delivery
  • Track 1-3Targeted Drug Delivery System
  • Track 1-4Vaccine Delivery System
  • Track 1-5imitations of Novel Drug Delivery System
  • Track 1-6Nano Particulate Drug Delivery
  • Track 2-1Reverse Pharmacology
  • Track 2-2Regulatory Toxicology
  • Track 2-3Drug Interactions and Pharmacological Compatibilities
  • Track 2-4Plant Toxicology
  • Track 3-1Biosimilars Development
  • Track 3-2Biosimilars in Therapeutics
  • Track 3-3Clinical Trials of Biosimilars
  • Track 3-4Biosimilars Pipeline
  • Track 3-5Biosimilars in Oncology
  • Track 4-1Medical Practitioners
  • Track 4-2Drug Inspectors
  • Track 4-3Drug Analysts
  • Track 4-4Technology Transfer
  • Track 4-5Pharmaceutical Technology Assessment
  • Track 4-6Quality assurance
  • Track 4-7Bioinformatics and Computational Biology
  • Track 4-8Pharmacological Technology Advances
  • Track 4-9Pharmaceutical Packaging and labeling
  • Track 5-1Innovative Strategies of Drug Design & Development
  • Track 5-2Synthesis in Drug Discovery
  • Track 5-3Pharmacogenetics in Drug Discovery
  • Track 5-4Stages of Drug Discovery
  • Track 5-5Structure Based Drug Design
  • Track 5-6Drug Targets
  • Track 5-7Drug Release Testing
  • Track 6-1ioequivalence Assessment
  • Track 6-2Hepatic First-Pass Effect
  • Track 6-3Factors Influencing Bioavailability
  • Track 6-4Route of Administration
  • Track 6-5Relative Bioavailability
  • Track 6-6In vitro Bioequivalence
  • Track 6-7Bioequivalence of Endogenous Substances
  • Track 6-8Therapeutic Index
  • Track 7-1Preclinical Trials
  • Track 7-2Phases of Clinical Trials
  • Track 7-3Dose-Response
  • Track 7-4Drug Safety and Efficacy
  • Track 7-5Data Interpretation
  • Track 7-6Clinical Trial Formulations
  • Track 8-1Marine Pharmacognosy
  • Track 8-2Medical Ethnobotany
  • Track 8-3Phytotherapy
  • Track 8-4Traditional Medicine Inspired Drug Discovery
  • Track 8-5Ethnopharmacy
  • Track 8-6Comparative Phytochemistry
  • Track 8-7Bioactivities of Phytochemicals
  • Track 8-8Molecular Genetics and Genomics
  • Track 8-9Protein Biochemistry and Proteomics
  • Track 8-10Plant Metabolomics
  • Track 8-11Ecological Biochemistry
  • Track 9-1Patient Safety
  • Track 9-2Emergency Care
  • Track 9-3Safety Assessment
  • Track 9-4Pharmaceutical Care Management
  • Track 9-5Medication Management Services
  • Track 10-1Formulation Types
  • Track 10-2Sources of Drug Formulation
  • Track 10-3Advanced Formulation Techniques
  • Track 10-4Chromatography Techniques
  • Track 10-5Spectroscopy Techniques
  • Track 10-6Electrochemical Methods
  • Track 10-7Titrimetric Techniques
  • Track 11-1Phenotypic Screening
  • Track 11-2Organs -On-A-Chip
  • Track 11-3Bioprinting
  • Track 11-4New Antibiotics Discovery
  • Track 11-5doption of Artificial Intelligence by Pharma and Biotech
  • Track 12-1Clinical Pharmacy : Activites and Prescriptions
  • Track 12-2Clinical Pharmacists : Roles and Responsibilities
  • Track 12-3Hospital Pharmacy and Health Practice
  • Track 12-4Pharmacy Practice
  • Track 12-5Community Practice
  • Track 12-6Clinical drug Development
  • Track 12-7Home Health Care Pharmacy
  • Track 12-8Managed Care Pharmacy
  • Track 12-9Health Care and Hospital Management
  • Track 12-10Medication Therapy Management (MTM)
  • Track 13-1Pharma Marketing
  • Track 13-2Pharma Digitization
  • Track 13-3Pharmaceutical Supply and Distribution Chain
  • Track 13-4Market Access
  • Track 13-5Market Intelligence
  • Track 13-6Home Health Pharmacy
  • Track 14-1Drug Regulations and Organization
  • Track 14-2Global Pharma Products Registration
  • Track 14-3Safety and Quality Regulation in Labelling
  • Track 14-4Application of Drug Safety
  • Track 14-5Reporting of ADR

 

 

  • Track 15-1Pharmaceutical Research
  • Track 15-2Pharmaceutical Chemistry
  • Track 15-3Biopharmaceutics
  • Track 15-4Pharmacokinetics
  • Track 15-5Pharmaceutical Toxicology
  • Track 15-6Pharmaceutical Microbiology
  • Track 15-7Clinical Efficacy and Safety Evaluation
  • Track 16-1Hospital Pharmacy
  • Track 16-2Clinical Pharmacy
  • Track 16-3Ambulatory Care Pharmacy
  • Track 16-4Compounding Pharmacy
  • Track 16-5Consultant Pharmacy
  • Track 16-6Internet Pharmacy
  • Track 16-7Pharmacy Informatics
  • Track 16-8Military Pharmacy